"Diabetes Complications" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
Descriptor ID |
D048909
|
MeSH Number(s) |
C19.246.099
|
Concept/Terms |
Diabetes Complications- Diabetes Complications
- Diabetes Complication
- Diabetes-Related Complications
- Diabetes Related Complications
- Diabetes-Related Complication
- Diabetic Complications
- Diabetic Complication
- Complications of Diabetes Mellitus
- Diabetes Mellitus Complication
- Diabetes Mellitus Complications
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Complications".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Complications".
This graph shows the total number of publications written about "Diabetes Complications" by people in this website by year, and whether "Diabetes Complications" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1997 | 0 | 1 | 1 |
1998 | 2 | 1 | 3 |
1999 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 2 | 3 | 5 |
2003 | 2 | 4 | 6 |
2004 | 2 | 5 | 7 |
2005 | 1 | 7 | 8 |
2006 | 4 | 2 | 6 |
2007 | 4 | 3 | 7 |
2008 | 4 | 3 | 7 |
2009 | 5 | 4 | 9 |
2010 | 5 | 5 | 10 |
2011 | 5 | 2 | 7 |
2012 | 3 | 3 | 6 |
2013 | 5 | 3 | 8 |
2014 | 4 | 5 | 9 |
2015 | 3 | 2 | 5 |
2016 | 5 | 3 | 8 |
2017 | 1 | 0 | 1 |
2018 | 5 | 2 | 7 |
2019 | 2 | 0 | 2 |
2020 | 6 | 1 | 7 |
2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Complications" by people in Profiles.
-
Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci. 2021 Nov 15; 22(22).
-
Aortic valve disease in diabetes: Molecular mechanisms and novel therapies. J Cell Mol Med. 2021 10; 25(20):9483-9495.
-
Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021 02; 9(2):117-126.
-
Outcomes in adults with systolic blood pressure between 130 and 139?mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial. J Hypertens. 2020 08; 38(8):1567-1577.
-
Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era. Am J Med Sci. 2020 10; 360(4):423-426.
-
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020 07; 52(7):680-691.
-
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175.
-
Endothelin-1 (ET-1) promotes a proinflammatory microglia phenotype in diabetic conditions. Can J Physiol Pharmacol. 2020 Sep; 98(9):596-603.
-
Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium). Pancreatology. 2020 Apr; 20(3):325-330.
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019 08; 7(8):618-628.